Formycon AG Trading Update – Friday, 23 Oct 2026
Ticker: FYB.DEExchange: Frankfurt Stock Exchange (and other European exchanges)
Current Market Snapshot
- Closing price (07:17 AM CET, 23 Oct 2026): €18.98
- Intraday change: +2.84 %
- Shares outstanding: 17.7 million
- Market capitalisation: €375.7 million
- Volume (last 24 h): €50.4 k
- Simple moving average (200 days): €19.98
Recent Performance
- Monthly trend: -1.01 % since the previous month‑end.
- 52‑week high: €26.95 (01 May 2026).
- 52‑week low: €15.80 (23 Mar 2026).
Comparison with Peer Stocks (last 24 h)
| Ticker | Last 24 h Move | Current Price | Market Cap (€ mn) | P/E Ratio |
|---|---|---|---|---|
| M12.DE (M1 Kliniken) | +4.85 % | €19.38 | 401.3 | 19.43 |
| PBB.DE (Deutsche Pfandbriefbank) | +0.14 % | €2.85 | 423.9 | – |
| WBAH.F (Wild Bunch) | 0 % | €15.20 | 395.6 | – |
| STM.DE (Stabilus) | –0.62 % | €15.52 | 427.4 | 6.97 |
| DR0.DE (Deutsche Rohstoff) | +2.63 % | €86.20 | 446.5 | 2.77 |
All values are rounded to two decimal places.
Company Overview
Formycon AG is a biopharmaceutical firm with more than twelve years of experience in product development. The company concentrates on developing and marketing biosimilars, which are biopharmaceuticals closely matching existing drugs whose patent protection is expiring. In addition, Formycon provides contract services to other biotechnology and pharmaceutical companies.
